<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39187623</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-742X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Aug</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of thrombosis and thrombolysis</Title><ISOAbbreviation>J Thromb Thrombolysis</ISOAbbreviation></Journal><ArticleTitle>The potential role of factor XI inhibitors in managing long COVID.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11239-024-03031-9</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kow</LastName><ForeName>Chia Siang</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>School of Pharmacy, IMU University, Bukit Jalil, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramachandram</LastName><ForeName>Dinesh Sangarran</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>School of Pharmacy, IMU University, Bukit Jalil, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Pharmacy, Monash University Malaysia, Bandar Sunway, Subang Jaya, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasan</LastName><ForeName>Syed Shahzad</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>School of Pharmacy, IMU University, Bukit Jalil, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thiruchelvam</LastName><ForeName>Kaeshaelya</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3754-1690</Identifier><AffiliationInfo><Affiliation>School of Pharmacy, IMU University, Bukit Jalil, Kuala Lumpur, Malaysia. kaeshaelya@imu.edu.my.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Thromb Thrombolysis</MedlineTA><NlmUniqueID>9502018</NlmUniqueID><ISSNLinking>0929-5305</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>26</Day><Hour>23</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39187623</ArticleId><ArticleId IdType="doi">10.1007/s11239-024-03031-9</ArticleId><ArticleId IdType="pii">10.1007/s11239-024-03031-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ, Long COVID (2023) major findings, mechanisms and recommendations [published correction appears in Nat Rev Microbiol. ;21(6):408]. Nat Rev Microbiol. 2023;21(3):133&#x2013;146</Citation></Reference><Reference><Citation>Tziolos NR, Ioannou P, Baliou S, Kofteridis DP (2023) Long COVID-19 pathophysiology: what do we know so far? Microorganisms 11(10):2458</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11102458</ArticleId><ArticleId IdType="pubmed">37894116</ArticleId><ArticleId IdType="pmc">10609046</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali AE, Awad MK, Ali K, Abouzid MR, Ahmed MH, Mazroua MS Factor XI as a new target for prevention of thromboembolism in cardiovascular disease: a meta-analysis of randomized controlled trials. J Thromb Thrombolysis</Citation></Reference><Reference><Citation>Schuermans A, Verstraete A, Lammi V et al (2024) Proteogenomic analyses identify coagulation factor XI as a thromboinflammatory mediator of long COVID. Preprint medRxiv. ;2024.05.17.24307553.</Citation></Reference><Reference><Citation>Nicolai L, Kaiser R, Stark K (2023) Thromboinflammation in long COVID-the elusive key to postinfection sequelae? J Thromb Haemost 21(8):2020&#x2013;2031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtha.2023.04.039</ArticleId><ArticleId IdType="pubmed">37178769</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>